DOSSIERS / CAPITOL PHARMA
← SearchExport PDF
Company dossier

CAPITOL PHARMA

FRANCE · COMPANY · INCORPORATED 2009-09-08
KYBE ID: FR-514687375 · 514687375 · 2 sources
RISK SCORE16LOW RISK

Key facts

active
CAPITOL PHARMA
fr_insee
514687375
fr_insee
active
fr_insee
Simplified joint-stock company (SAS)
fr_insee
2009-09-08
fr_insee
8 CHE DE LA PLAINE, 31770 COLOMIERS
fr_insee
46.46Z
fr_insee
10
fr_insee
€39,620
fr_insee

Connections

22 links
Showing 15 of 22 — full graph via /v1/entities/FR-514687375/network.

People with significant control

2 people
NameRoleFromSource
NICOLAS EMERYDirecteur général déléguéFrance registry
GUILHEM BOYERPrésident du conseil d'administrationFrance registry

Risk signals

2 matched
high

Business fragmentation

A director is shared across 21 companies — business-splitting (дробление) pattern

medium

Politically exposed person (PEP)

NICOLAS EMERY (officer) matches PEP Nicholas Emery — member of the Maine House of Representatives, United States. Apply enhanced due diligence.

Risk journey — why 16?

2 signals
+16
Business fragmentation
+0
Politically exposed person (PEP)
Composite risk score16/100

Filed accounts

9 years
YearRevenueNet incomeTotal assetsEmployees
2024€3,646,909€10,784€1,876,043
2023€3,977,611€-42,558€2,063,984
2022€3,499,803€54,005€1,529,419
2021€3,551,809€41,930€1,588,740
2020€3,657,663€73,373€1,478,769
2019€3,316,063€72,240€1,397,582
2018€2,942,784€72,340€1,225,600
2017€2,582,649€27,350€1,218,737
2016€2,029,315€58,243€1,041,787
From official financial statements filed with the registry.